Targeted therapy for head and neck cancer: signaling pathways and clinical studies

Q Li, Y Tie, A Alu, X Ma, H Shi - Signal transduction and targeted …, 2023‏ - nature.com
Head and neck cancer (HNC) is malignant, genetically complex and difficult to treat and is
the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major …

International consensus statement on allergy and rhinology: sinonasal tumors

EC Kuan, EW Wang, ND Adappa… - International forum of …, 2024‏ - Wiley Online Library
Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …

Recent progress in functionalized and targeted polymersomes and chimeric polymeric nanotheranostic platforms for cancer therapy

M Beygi, F Oroojalian, SS Hosseini… - Progress in Materials …, 2023‏ - Elsevier
The majority of advances in cancer therapy have been achieved based on developments in
public awareness, as well as novel diagnostic and therapeutic modalities. Treatment …

[HTML][HTML] European Head and Neck Society recommendations for head and neck cancer survivorship care

I Verdonck-de Leeuw, C Dawson, L Licitra, JG Eriksen… - Oral oncology, 2022‏ - Elsevier
Survivors of head and neck cancer can experience long-term consequences of the cancer
and subsequent treatments even after the cancer has resolved. Increasingly clinicians are …

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

D Rischin, NI Khushalani, CD Schmults… - Journal for …, 2021‏ - pmc.ncbi.nlm.nih.gov
Background To provide pooled longer term data from three groups of a phase 2 study of
cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC), and to …

Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe

D Albano, M Benenati, A Bruno, F Bruno, M Calandri… - Insights into …, 2021‏ - Springer
Newer biologic drugs and immunomodulatory agents, as well as more tolerated and
effective radiation therapy schemes, have reduced treatment toxicity in oncology patients …

Head and neck cancer: United Kingdom national multidisciplinary guidelines

JJ Homer, SC Winter - The Journal of Laryngology & Otology, 2024‏ - cambridge.org
The Journal of Page 1 The Journal of Laryngology &Otology VOLUME 138 | NUMBER S1 |
APRIL 2024 ISSN: 0022-2151 Founded in 1887 By Morell Mackenzie and Norris Wolfenden …

The power of phages: revolutionizing cancer treatment

MS Islam, J Fan, F Pan - Frontiers in Oncology, 2023‏ - frontiersin.org
Cancer is a devastating disease with a high global mortality rate and is projected to increase
further in the coming years. Current treatment options, such as chemotherapy and radiation …

A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis

P Jimenez-Labaig, C Aymerich, I Brana… - JNCI Cancer …, 2024‏ - academic.oup.com
Background Patients with head and neck cancer present particularly considerable levels of
emotional distress. However, the actual rates of clinically relevant mental health symptoms …

[HTML][HTML] Development of anticancer peptides using artificial intelligence and combinational therapy for cancer therapeutics

JS Hwang, SG Kim, TH Shin, YE Jang, DH Kwon… - Pharmaceutics, 2022‏ - mdpi.com
Cancer is a group of diseases causing abnormal cell growth, altering the genome, and
invading or spreading to other parts of the body. Among therapeutic peptide drugs …